Apheresis Market is expected to grow at a CAGR of 9.1% during the forecasted period | Evolve Business Intelligence

As per the study initiated by Evolve Business Intelligence, the global Apheresis Market size accounted for USD 4.5 Billion in 2023, growing at a CAGR of 9.1% from 2023 to 2033. Apheresis is a medical technology that involves the separation and extraction of specific components from a patient's blood and the return of the remaining blood components to the patient. The primary purpose of apheresis is to selectively remove or collect particular blood components, such as plasma, platelets, or white blood cells. This process allows healthcare professionals to treat various medical conditions by modifying the patient's blood composition.

Request/Download PDF Sample: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021949

Apheresis is often used in the treatment of various blood disorders, including leukemia, myeloma, and certain autoimmune diseases. The increasing prevalence of these conditions contributes to the growing demand for apheresis procedures. Ongoing advancements in apheresis technology, such as improved automation, better separation techniques, and increased efficiency, drive the market by making the procedures more effective, safer, and less time-consuming. The growing demand for blood components, such as plasma, platelets, and red blood cells, for transfusions and other medical treatments fuels the need for apheresis procedures. Increased awareness among healthcare professionals and patients about the benefits of apheresis in treating various conditions contributes to its growing acceptance and adoption. Apheresis is finding applications in a widening range of medical conditions beyond traditional uses. For example, it is increasingly used in neurology for the treatment of neurological disorders.

Key Players
Some of the major Apheresis Market players holding high market shares include Asahi Kasei Corporation, B. Braun Melsungen AG, Cerus Corporation, Fresenius Kabi, and Haemonetics Corporation. These players use partnership and collaboration as a key strategy to gain significant market share to compete with market leaders. Some of the other major market players include Charles River Laboratories International, Inc., Kaneka Corporation, Kawasumi Laboratories Inc., Nikkiso Co. Ltd, and Terumo BCT.

For More Information: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021949

Segmental Analysis
Based on product, the Apheresis market is segmented into Devices, Disposable and Reagents, and Software. The devices segment is expected to be the largest, driven by the increasing demand for technologically advanced and user-friendly apheresis machines. Technological advancements like automation, improved safety features, and data integration contribute to their popularity.
Based on components, the Apheresis market is Plasma (Plasmapheresis), Platelets (Plateletpheresis), Leukocytes (Leukapheresis or leukopheresis), Lymphocytes (Lymphopheresis or lymphapheresis), RBC's (Erythropheresis). Plasma (Plasmapheresis) accounts for the largest share due to its widespread use in treating various autoimmune and neurological disorders. Plasmapheresis is also a crucial component of blood product preparation and plasma exchange therapy.

Based on the method, the Apheresis market is Centrifugation, Membrane Separation, and Selective Adsorption. Centrifugation traditional method remains dominant due to its established efficacy and affordability. Centrifugation technology is well-understood and readily available, making it a reliable choice for many institutions.
Based on procedure, the Apheresis market is Donor/Automated Apheresis, Therapeutic Apheresis. The therapeutic Apheresis segment is projected to be the largest due to the rising prevalence of chronic diseases requiring apheresis treatment, such as autoimmune disorders, neurological conditions, and certain cancers.
Based on end-users, the Apheresis market is segmented into Blood Centers, Hospitals, and Other End Users. The hospital segment is expected to hold the largest share due to the high volume of patients requiring apheresis treatment in hospital settings. Hospitals have the necessary infrastructure and medical expertise to perform apheresis procedures effectively

Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Spain, Russia, Nordic Countries, BeNeLux, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Rest of Asia Pacific)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA)
• Latin America (Mexico, Brazil, Argentina, Rest of Latin America)

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from Fortune's global 2000 companies.

This release was published on openPR.